Wang Jinyu, Hogg Philip J, Xu Xulin, Fang Chao
Department of Pharmacology, School of Basic Medicine, Tongji Medical College, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
School of Stomatology, Tongji Medical Collage, Key Laboratory of Oral and Maxillofacial Development and Regeneration of Hubei Province, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.
Thromb J. 2025 Jul 28;23(1):76. doi: 10.1186/s12959-025-00765-1.
Protein disulfide isomerase (PDI) catalyzes the reduction, oxidation, and isomerization of disulfide bonds. Although initially discovered as an endoplasmic reticulum (ER)-residing protein, PDI has been demonstrated to play critical roles on cell surfaces and in the extracellular milieu under different pathophysiological settings. During thrombosis extracellular PDI regulates both platelet activation and coagulation, while during vascular injury PDI modulates proinflammatory neutrophil recruitment and the homeostasis of vascular cells. The identification of PDI substrates using mass spectrometry-based techniques such as mechanism-based kinetic trapping and differential cysteine alkylation has significantly advanced our understanding of the mechanisms whereby extracellular PDI regulates these pathophysiological processes. PDI may reduce or oxidize allosteric disulfide bonds and change the function of adhesive receptors, coagulation-related plasma proteins and signaling molecules that are important during thrombosis and vascular injury responses. The catalytic cysteines of PDI can also be post-translationally modified to enable PDI to transmit redox active species. This review aims to summarize the most recent advances about the roles of extracellular PDI in thrombosis and vascular injury and their mechanisms. With the discovery of novel PDI inhibitors, this body of knowledge will provide novel opportunities to develop strategies for the treatment of thrombotic and vascular diseases.
蛋白质二硫键异构酶(PDI)催化二硫键的还原、氧化和异构化。尽管最初被发现是一种驻留在内质网(ER)中的蛋白质,但已证明PDI在不同病理生理环境下的细胞表面和细胞外环境中发挥关键作用。在血栓形成过程中,细胞外PDI调节血小板活化和凝血,而在血管损伤过程中,PDI调节促炎中性粒细胞募集和血管细胞的稳态。使用基于质谱的技术(如基于机制的动力学捕获和差异半胱氨酸烷基化)鉴定PDI底物,极大地推进了我们对细胞外PDI调节这些病理生理过程机制的理解。PDI可能还原或氧化变构二硫键,并改变在血栓形成和血管损伤反应中起重要作用的黏附受体、凝血相关血浆蛋白和信号分子的功能。PDI的催化半胱氨酸也可以进行翻译后修饰,使PDI能够传递氧化还原活性物质。本综述旨在总结细胞外PDI在血栓形成和血管损伤中的作用及其机制的最新进展。随着新型PDI抑制剂的发现,这一知识体系将为开发治疗血栓性和血管性疾病的策略提供新的机会。
Thromb J. 2025-7-28
Psychopharmacol Bull. 2024-7-8
Arch Ital Urol Androl. 2025-6-30
2025-1
Res Pract Thromb Haemost. 2025-2-27
Arterioscler Thromb Vasc Biol. 2025-4
Thromb J. 2024-12-18